BLU-808

N/A

Report date: 2026/03/27 20:01:50
NMEFirst In Class

Base Information

Drug NameBLU-808
Drug Alias NameBLU-808SAR-449028
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cell growth factor receptor inhibitors
TargetsStem cell growth factor receptor
Therapy Area/IndicationsChronic UrticariaConjunctivitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[7
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBlueprint Medicines Corp
China Registration ClassN/A

Develop Information

Active CompaniesBlueprint Medicines Corp
Inactive CompaniesN/A
Active IndicationsChronic UrticariaConjunctivitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A